These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8830012

  • 1. The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii.
    Stapleton P, Shannon K, Phillips I.
    J Antimicrob Chemother; 1995 Sep; 36(3):483-96. PubMed ID: 8830012
    [Abstract] [Full Text] [Related]

  • 2. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K, Phillips I.
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [Abstract] [Full Text] [Related]

  • 3. Interactions of FCE 22101 with class I beta-lactamases.
    Yang Y, Livermore DM.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():85-94. PubMed ID: 2786519
    [Abstract] [Full Text] [Related]

  • 4. DNA sequence differences of ampD mutants of Citrobacter freundii.
    Stapleton P, Shannon K, Phillips I.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2494-8. PubMed ID: 8585732
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
    Livermore DM, Yang YJ.
    J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630
    [Abstract] [Full Text] [Related]

  • 10. Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora.
    Stark C, Edlund C, Hedberg M, Nord CE.
    Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):18-24. PubMed ID: 7729448
    [Abstract] [Full Text] [Related]

  • 11. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
    Curtis NA, Eisenstadt RL, Rudd C, White AJ.
    J Antimicrob Chemother; 1986 Jan; 17(1):51-61. PubMed ID: 3485092
    [Abstract] [Full Text] [Related]

  • 12. Ciprofloxacin, salicylate, and 2,4-dinitrophenol decrease production of AmpC-type beta-lactamase in two Citrobacter freundii clinical isolates.
    Tavío MM, Perilli M, Vila J, Becerro P, Ruiz J, Amicosante G, De Anta MT.
    Microb Drug Resist; 2005 Jan; 11(3):225-31. PubMed ID: 16201924
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and laboratory significance of inducible beta-lactamases].
    Bedenić B, Zagar Z.
    Lijec Vjesn; 1995 Jan; 117(9-10):249-53. PubMed ID: 8643019
    [Abstract] [Full Text] [Related]

  • 14. Broad spectrum beta-lactamases of Citrobacter diversus.
    Oliva B, Segatore B, Amicosante G, Franceschini N, Oratore A, Bennett PM.
    J Antimicrob Chemother; 1990 Mar; 25(3):335-41. PubMed ID: 2338412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC, Shlaes DM.
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.